Coudereau, R.; Monneret, G.; Lukaszewicz, A.-C.; Py, B.F.; Argaud, L.; Cour, M.; Bidar, F.; Gossez, M.; Venet, F.
Altered Ex Vivo NLRP3 Inflammasome Activation Is Associated with 28-Day Mortality in Septic Patients. Viruses 2023, 15, 2419.
https://doi.org/10.3390/v15122419
AMA Style
Coudereau R, Monneret G, Lukaszewicz A-C, Py BF, Argaud L, Cour M, Bidar F, Gossez M, Venet F.
Altered Ex Vivo NLRP3 Inflammasome Activation Is Associated with 28-Day Mortality in Septic Patients. Viruses. 2023; 15(12):2419.
https://doi.org/10.3390/v15122419
Chicago/Turabian Style
Coudereau, Rémy, Guillaume Monneret, Anne-Claire Lukaszewicz, Bénédicte F. Py, Laurent Argaud, Martin Cour, Frank Bidar, Morgane Gossez, and Fabienne Venet.
2023. "Altered Ex Vivo NLRP3 Inflammasome Activation Is Associated with 28-Day Mortality in Septic Patients" Viruses 15, no. 12: 2419.
https://doi.org/10.3390/v15122419
APA Style
Coudereau, R., Monneret, G., Lukaszewicz, A.-C., Py, B. F., Argaud, L., Cour, M., Bidar, F., Gossez, M., & Venet, F.
(2023). Altered Ex Vivo NLRP3 Inflammasome Activation Is Associated with 28-Day Mortality in Septic Patients. Viruses, 15(12), 2419.
https://doi.org/10.3390/v15122419